Add BrightSurf on Google Email

Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds

A UCLA study found that patients with cancer who used biosimilars had lower average monthly costs for insurers and patients, with savings of $3,820 for insurers and $39.50 for patients. The study also found that biosimilar entry led to lower prices and declining market share for the original branded biologic drugs.

Nearly 3 out of 10 health and social care workers in Europe may be exposed to cancer risk factors

A new ISGlobal study found that nearly 30% of health and social care workers in Europe were exposed to at least one cancer risk factor, with radiation, diesel engine exhaust emissions, and certain chemicals being the main risks. The study highlights the need for prevention strategies tailored to real working conditions in this field.

SourceBarcelona Institute for Global Health (ISGlobal)·JournalEuropean Journal of Public Health·TypeSurvey·DateMay 27, 2026

NCCN 2026 Annual Conference prepares cancer care providers worldwide for healing the whole patient

The NCCN 2026 Annual Conference emphasized the need for holistic care for adolescents and young adults with cancer, highlighting unique challenges and the importance of supportive services. The conference also addressed global cancer care realities and future strategies, emphasizing the need for collaboration and investment to address ...

Study finds most cancer patients exposed to misinformation. Researchers pilot 'information prescription.'

A study by University of Florida researchers found that 93% of new cancer patients are exposed to at least one type of misinformation about cancer treatments. The most common sources were second-hand information from friends, family, social media, and news outlets. The study suggests that clinicians should assume their patients have be...

SourceUniversity of Florida·JournalJournal of Cancer Education·TypeSurvey·DateSep 24, 2025

Scientists develop super strong antibodies for new cancer treatment

Researchers from the University of Southampton engineered a new type of super-strong antibody that triggers a stronger response from the immune system compared to naturally produced antibodies. The study confirms that making subtle increases in rigidity stimulates immune activity, creating a powerful immune response against disease.

SourceUniversity of Southampton·JournalNature Communications·TypeExperimental study·DateMay 1, 2025

Perspectives on obesity management and the use of anti-obesity medicine

A new study found that both employed people with obesity and employer representatives acknowledge the impact of obesity on future health problems and perceive lifestyle change alongside anti-obesity medications as the most effective approach for maintaining weight-loss reduction. Cost of medication coverage remains a significant barrie...

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalPopulation Health Management·TypeSurvey·DateApr 9, 2025

New research in JNCCN finds stark disparities in treatment and survival time for people with pancreatic cancer

Researchers found significant disparities in quality of care and outcomes for patients with metastatic pancreatic cancer. Patients with higher social vulnerability indices were less likely to receive guideline-concordant systemic therapy, palliative care, or survive over 12 months.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateApr 9, 2025

Patient advocates from NCCN guidelines panels share their ‘united by unique’ stories for world cancer day

The National Comprehensive Cancer Network is joining the global effort to improve awareness and knowledge of cancer risks through its 'United by Unique' campaign. Patient advocates from NCCN guidelines panels are sharing their personal stories to highlight the importance of a people-centered approach in cancer care, which recognizes ev...

NCCN joins international meeting to improve cancer care in the Middle East and North Africa region

The National Comprehensive Cancer Network (NCCN) has joined a two-day meeting in Riyadh, Saudi Arabia, to review updated NCCN Clinical Practice Guidelines for the MENA region. The guidelines provide evidence-based expert consensus-driven recommendations for cancer prevention, screening, treatment, and supportive care, tailored for uniq...

Artificial intelligence improves mammography-based risk prediction

Artificial intelligence is enhancing breast cancer risk prediction through mammographic analysis, uncovering key features that predict breast cancer risk. These AI-generated features may inform personalized screening strategies, such as more frequent or less frequent screenings for women at high or low risk of breast cancer.

SourceCell Press·JournalTrends in Cancer·TypeCommentary/editorial·DateDec 12, 2024

National Comprehensive Cancer Network joins with Vietnam National Cancer Hospital to enhance cancer treatment

The National Comprehensive Cancer Network has joined forces with the Vietnam National Cancer Hospital to create Harmonized Guidelines for Vietnam, a framework for improving and standardizing cancer care in the country. The guidelines are based on NCCN's Clinical Practice Guidelines in Oncology, with modifications to reflect local needs.

Study finds minorities more likely to have ‘free’ preventive healthcare denied by insurers

A new study published in JAMA Network Open found that racial and ethnic minorities are more likely to have claims for free preventive care denied by insurance plans, leading to unexpected bills or lack of access. Healthcare providers also charge disadvantaged groups a higher amount for preventive services.

SourceUniversity of Massachusetts Amherst·JournalJAMA Network Open·TypeData/statistical analysis·DateOct 3, 2024

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

A new study by Michigan Medicine found that the Inflation Reduction Act's limit on Medicare Part D spending leads to significant savings for cancer patients prescribed oral chemotherapy. The average annual cost for these medications decreased from $11,284 in 2023 to $3,927 in 2024, resulting in median cost savings of $7,260.

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeData/statistical analysis·DateSep 10, 2024

Chinese Medical Journal reports on emerging trends and implications of non-communicable diseases in China

Non-Communicable Diseases (NCDs) are a major global health issue, characterized by their chronic nature and long-term impact on quality of life. In China, understanding the extent and distribution of NCDs is essential for developing effective public health strategies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateSep 4, 2024

Risky drinking even riskier for women

A significant number of Australian women (over 300,000) are drinking at very high-risk levels, with a greater proportion of men consuming alcohol at similar rates. Women are more susceptible to health problems from excessive drinking and may be affected by their natural biological rhythms.

SourceFlinders University·JournalDrug and Alcohol Review·TypeSystematic review·DateJun 20, 2024

Flavor restrictions affect tobacco buyers differently depending on socioeconomic status, researchers say

Researchers found that restricting menthol flavor in cigarettes while making nicotine replacement therapy more available can decrease socioeconomic disparities in tobacco use. The study used an online platform to simulate the effects of policy changes on purchase behavior, showing that policies must consider interplay to be effective.

SourceVirginia Tech·JournalNicotine & Tobacco Research·TypeData/statistical analysis·DateJun 6, 2024

Affordable Care Act expansions improved access to cancer care, study suggests

A study published by University of Pittsburgh researchers found that ACA insurance expansions led to an increase in patients receiving care at accredited cancer hospitals in Pennsylvania. The study suggests that these expansions make a difference in improving access to high-quality cancer care, particularly for those living in areas wi...

SourceUniversity of Pittsburgh·JournalHealth Services Research·TypeData/statistical analysis·DateMay 3, 2024